$SVA

$6.47 +$0.00 (0.0%) Close

$SVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 71.9M shares outstanding

Who owns SVA?

By type of holder

Institutions 14.5% Insiders 9.1% Everyone else 76.4%

Concentration Top 10 holders own 80.2%

1Globe Capital LLC 25.8% · SAIF Partners IV L.P. 15.0%

Institutional ownership

14.5%

-0.1 pts vs last qtr

Institutional holders

-1 vs last qtr

Net shares bought

−44.6K

by institutions in Q2 2026

New / sold out

3 / 4

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Navellier & Associates Inc NEW +13.0K
UBS Group AG +250

Biggest sellers in Q2 2026

Skandinaviska Enskilda Banken AB (publ) −40.0K
Susquehanna International Group, LLP SOLD OUT −16.4K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Sinovac Biotech Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+26.2%

+2.62% a year

Each share's claim on the business

−20.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $28.6M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years3% 3–5 years26% 1–3 years71% Under 1 year0%

Quarterly turnover

0.3%

of institutional shares changed hands

Top 10 managers, median time held

1 year

Super Investors

Investment managers reporting SVA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
VC Vivo Capital, LLC	5.9M	8.21%	Unchanged	2025	3.5%
Shares held by quarter Peak holding11.8M (Q3'24) Change over 8 quarters−5.9M Share of the company8.210% Vivo Capital, LLC's full portfolio →
OA Orbimed Advisors LLC	2.7M	3.78%	Unchanged	2022	3.4%
Shares held by quarter Peak holding2.7M (Q3'24) Change over 8 quarters0 Share of the company3.780% Orbimed Advisors LLC's full portfolio →

Vivo Capital, LLC

5.9M

% of company

8.21%

Change vs last qtr

Unchanged

Held since

2025

Orbimed Advisors LLC

2.7M

% of company

3.78%

Change vs last qtr

Unchanged

Held since

2022

27 more super investors behind a free account

See every manager holding Sinovac Biotech Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting SVA on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
YS Yorktown Small Cap Fund American Pension Investors Trust	$194K	74.9K	0.10%	0.64%	July 31, 2023
NS Northern Small Cap Core Fund Northern Funds	—	1.6K	0.00%	0.00%	December 29, 2023

Yorktown Small Cap Fund

American Pension Investors Trust

Position value

$194K

% of company

0.10%

% of the fund

0.64%

As of

July 31, 2023

Northern Small Cap Core Fund

Northern Funds

Position value

—

% of company

0.00%

% of the fund

0.00%

As of

December 29, 2023

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
1C 1Globe Capital LLC 5%+ holder 13D · 32.3%	18.5M	25.77%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company25.770% Disclosed stake13D · 32.3% View the 13D/G filing →
SP SAIF Partners IV L.P. 5%+ holder 13D · 15.0%	10.8M	15.00%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company15.000% Disclosed stake13D · 15.0% View the 13D/G filing →

1Globe Capital LLC

5%+ holder13D · 32.3%

18.5M

% of company

25.77%

Change vs last qtr

—

Held since

—

SAIF Partners IV L.P.

5%+ holder13D · 15.0%

10.8M

% of company

15.00%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Sinovac Biotech Ltd.

Comments